Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
    43.
    发明授权
    Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter 有权
    选择和使用乳酸菌减少幽门螺杆菌引起的炎症

    公开(公告)号:US07105336B2

    公开(公告)日:2006-09-12

    申请号:US10265859

    申请日:2002-10-07

    IPC分类号: C12N1/20 C12N1/12

    摘要: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.

    摘要翻译: 已被选择用于减少胃肠道炎症的能力的乳杆菌菌株,例如由于幽门螺杆菌引起的,以及源自这些菌株的产品,包括用于治疗或预防与幽门螺杆菌相关的炎症的药剂用于给予人,并且包括条件培养基 其中选择的菌株已经生长并且含有条件培养基的含蛋白质的提取物。

    Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae
    45.
    发明申请
    Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae 审中-公开
    选择增强对肺炎链球菌的免疫应答的乳酸菌

    公开(公告)号:US20050220777A1

    公开(公告)日:2005-10-06

    申请号:US10991891

    申请日:2004-11-18

    摘要: A method of selection of lactic acid bacteria for providing a method of protecting humans against Streptococcus pneumoniae infections by selecting a lactic acid bacterial strain (LAB) naturally carrying genes coding for proteins similar to the PspC, choline binding protein of S. pneumoniae so that the selected LAB can be used in various products for oral and nasal administration to humans as immune enhancers against S. pneumoniae, and products containing specifically selected LAB that naturally carry genes coding for proteins similar to PcpC binding protein of S. pneumoniae as oral and nasal immune enhancers for humans.

    摘要翻译: 选择乳酸菌的方法,通过选择天然携带编码类似于肺炎链球菌的PspC,胆碱结合蛋白的蛋白质的基因的乳酸菌株(LAB),从而提供一种保护人免受肺炎链球菌感染的方法, 选择的LAB可用于各种用于人类口服和鼻内给药的产品,作为针对肺炎链球菌的免疫增强剂,以及含有特异性选择的LAB的产品,其天然携带编码类似于肺炎链球菌的PcpC结合蛋白的蛋白质的基因作为口服和鼻免疫 人的增强剂。